Results 101 to 110 of about 2,461,363 (302)
BackgroundThe safety and long‐term outcome of systemic thrombolysis in patients receiving antiplatelet medications remain subjects of great clinical significance.
Shengyuan Luo +3 more
doaj +1 more source
Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study [PDF]
INTRODUCTION Current literature suggesting a higher bleeding risk during combination therapy compared to oral anticoagulation alone is primarily based on retrospective studies or specific populations.
Aujesky, Drahomir +9 more
core +1 more source
ABSTRACT Background Biodegradable‐polymer (BP) drug‐eluting stents (DES) were developed to mitigate potential late adverse events related to persistent durable polymers in durable‐polymer (DP) DES; however, contemporary long‐term real‐world comparative data remain limited. Aims We aimed to compare the 5‐year clinical outcomes of contemporary BP‐DES and
Yangyoun Lee +6 more
wiley +1 more source
Background. Current treatment of patients with myocardial infarction is based on the strategy of early invasive coronary intervention in combination with dual antiplatelet therapy - with acetylsalicylic acid and a P2Y12 blocker of platelet adenosine ...
T. R. Gvindzhiliya +6 more
doaj +1 more source
ABSTRACT Incomplete stent apposition at the proximal coronary artery may predispose to subtle guiding catheter–induced stent deformation, creating a gap between the stent and the vessel wall that facilitates inadvertent abluminal guidewire passage. We report a case in which balloon dilatation over an unrecognized abluminal guidewire resulted in severe ...
Yuto Abe +3 more
wiley +1 more source
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
William B Hillegass1, Brigitta C Brott2, James C Dobbs2, Silvio E Papapietro2, Vijay K Misra2, Gilbert J Zoghbi21Columbiana Cardiovascular Consultants, Columbiana, AL, USA; 2Interventional Cardiovascular Section, University of Alabama at Birmingham, AL ...
Hillegass B
core
Anti-platelet therapy in cardiovascular diseases
This thesis review the literature of the different mechanisms via which the antiplatelet agents exert their effects, exploring the arguments for and against their use.
Al-Awawdeh, Mitib Omar Falah
core
ABSTRACT The identification of the “culprit lesion” in acute coronary syndromes (ACS) traditionally relies on coronary angiography, assuming that the most severe stenosis, abrupt occlusion, or largest filling defect marks the site of plaque destabilization.
Fernando Quevedo‐Candela +7 more
wiley +1 more source
Background It remains unclear if intensive antiplatelet and statin treatments begun within 24–72 hours of cerebral ischaemic events from intracranial or extracranial atherosclerosis is effective or safe.Methods The Intensive Statin and Antiplatelet ...
Liping Liu +16 more
doaj +1 more source
ABSTRACT Background Percutaneous treatment of right coronary artery (RCA) ostial lesions is technically challenging due to cardiorespiratory motion. Case Summary We describe a 70‐year‐old man undergoing PCI for an ostial RCA lesion where a forceful cough caused complete stent expansion within the aortic root.
Fernando Quevedo‐Candela +2 more
wiley +1 more source

